article thumbnail

STAT+: Feds accuse CVS of filling ‘thousands’ of illicit opioid prescriptions

STAT

CVS Health was accused of contributing to a nationwide epidemic of opioid addiction and overdose by filling illegal opioid prescriptions and billing federal health insurance programs, according to a lawsuit unsealed Wednesday by the U.S. Department of Justice.

article thumbnail

STAT+: Carbon Health blasts a major insurer in rare public dispute over coverage

STAT

— Primary care startup Carbon Health blasted health insurer Elevance on Monday for paying it less than competitors and for also refusing to process out-of-network claims — a rare public escalation of the behind-the-scenes disputes between providers and payers. OAKLAND, Calif.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more

STAT

health insurers have agreed to start paying for the Wegovy weight-loss drug for certain people on Medicare with heart conditions, The Wall Street Journal reports. From 2013 to 2022, pharmaceutical and device companies made more than 85 million payments totaling $12.1 Well, whatever you do, have a grand time. But be safe.

article thumbnail

Health insurance statistics 2023

The Checkup by Singlecare

What is health insurance? | How common is health insurance? Health insurance stats by ethnicity | Health insurance stats by state | Health insurance stats by age group | Health insurance stats by type | Common complications | Costs | Treatment | FAQs | Research Health insurance is a hot topic these days.

article thumbnail

STAT+: Freespira bets on slow and steady, amid spectacular digital health collapses

STAT

based company was founded in 2013 and has raised $60 million to date. The Kirkland, Wash.-based Perekupka declined to disclose a valuation or whether it increased with the most recent fundraise.

Insurance 103
article thumbnail

STAT+: Drug industry payments to eye docs boosted Medicare spending on pricier treatments

STAT

million from 2013 to 2019, presumably due to the company payments, according to the study, which was published in JAMA Health Forum. Physicians who did not accept payments prescribed Avastin 46% of the time, nearly twice as often as those who accepted payments. As a result, Medicare shelled out an estimated $642.8

Insurance 130
article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

The report from Berkeley Research Group (BRG) – which was funded by the pharma industry trade group PhRMA – reveals a steady decrease in the proportion received by drugmakers from around 67% in 2013 to 49.5%